Search:

Login | Subscribe

Home > Companies > Osmetech

Price	Market	Sector	Market Cap
1.75p (-1.75p) -50.00%	AIM	Medicine and Biotech Research	£3.55m

Add to company folder | Print

Related Companies

AGY	10.00p	0.00%
APH	4.62p	0.00%
AZH	p
BBI	p
CEN	p
CBF	2.00p	0.00%
COT	91.50p	-0.54%
CRX	2.62p	0.00%
CYX	p
LAC	p
EVC	25.75p	0.00%
FUL	3.12p	0.00%
FUM	27.25p	-0.91%
GMX	1.75p	0.00%
GNI	p
GWP	29.50p	-0.84%
HML	0.42p	0.00%
MLR	p
MMG	7.25p	0.00%
MPM	9.75p	5.41%

Commentary

Healthcare diagnostics group

Recent Articles

Empire strikes back	04/11/2005
Osmetech	19/08/2004
Osmetech	29/01/2004
Aim Report	03/11/2003
Osmetech	30/07/2003
Osmetech	31/01/2003
Osmetech	29/01/2003
Osmetech	07/01/2003
Osmetech's FDA boost	22/11/2001
Osmetech	22/11/2001
More

Recent Announcements

Issue of Equity	04/12/2008
Clinical trials commence extended warfarin test	10/11/2008
Product Launch	04/11/2008
Wafarin test results and update on proposed ADS	31/10/2008
Result of EGM	01/10/2008
Interim Results	25/09/2008
Re Alliance	22/09/2008
Proposed issue of ADSs and new Ordinary Shares	12/09/2008
Directorate Change	12/08/2008
Product Launch	30/07/2008
More

Articles from the Sector

Stroke hope at ReNeuron	28/11/2008
Futura Medical	28/11/2008
Option deal boosts ImmuPharma	25/11/2008
Digital imager targets AIM	24/11/2008
Vectura loses interim £11.7m	24/11/2008
GW trims loss	19/11/2008
Asterand	18/11/2008
EU trial cheers Plethora	07/11/2008
IS Pharma	05/11/2008
Animalcare nurturing high-margin growth	03/11/2008
More

Financial History

Financial Year End	30/04/2003	30/04/2004	31/12/2005	31/12/2006	31/12/2007
Currency	GBP	GBP	GBP	GBP	GBP
Turnover	0.69	6.18	0.00	0.05	0.17
Operating Profit	-3.10	-1.42	-5.52	-12.75	-13.05
Pretax Profit	-3.83	-1.32	-5.33	-12.47	-12.18
Earnings After Tax	-3.67	-1.17	-5.14	-12.34	-12.03
Profit Available For Dividend	0.00	0.00	0.00	0.00	0.00
Ordinary Dividends	0.00	0.00	0.00	0.00	0.00
Retained Profit	-3.67	-1.17	0.00	0.00	0.00
Shareholders Funds	5.23	6.16	12.78	11.51	15.88
Net Current Assets	3.75	4.66	9.27	0.00	0.00
Adjusted Earnings Per Share Undiluted	0.00	0.00	0.00	-7.46	-5.93
Adj Earnings Per Share	0.00	0.00	0.00	-7.46	-5.93
Dividend Per Share	0.00	0.00	0.00	0.00	0.00

Chart

Click here for interactive charting

Company Details
Address	No.1 Liverpool Street, London, EC2M 7QD
Telephone	020 7849 6027
Fax	020 7956 2001
Executives
Chairman	Daryl Jay Faulkner (0.00% holding)
Chief Executive	James White (0.20% holding)
Finance Director	David Sandilands (0.10% holding)
Non-Exec Director	Gordon Kuenster (0.20% holding)
Main Shareholders
	Efficacy Capital: 16% Schroder Investment Management: 13.8% Gartmore: 12% Barclayshare Nominees: 6.8%
Advisers
Nominated Adviser	Canaccord Adams
Nominated Broker	Canaccord Adams
Solicitors	Ashurst
Auditors	Deloitte
Registrar	Capita Registrars

Commentary
Healthcare diagnostics group
Company Data
Code	OMH
Sedol	GB00B0K29R
Shares In Issue	203.117 m
Indices	Aim
Entry on AIM	03/10/2002
Interim Results	Sep
Final Results	Mar
Year End	Dec
Accounts Due	Sep
Int div payment	n/a
Fin div payment	n/a
Int net div per share	nil
Fin net div per share	nil
Probable CGT relief	Yes